LMAT | LeMaitre VascularNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history

$80.60
-$0.66 (-0.81%)

LeMaitre Vascular (LMAT) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2018.

The 50 SMA has sat below the 200 on the daily since Aug 2026, with no cross projected inside the 30 bars Cruxta tracks. On both the daily and the 4-hour, price sits below the 50 and the 200; on the weekly it is between the two.

Timeframe summary

Daily as of 3 Nov 16:00 ET

Price
below both $80.60 vs 50 $81.20 / 200 $94.40
Projection
No cross projected
Test
No active test
Last cross
Death cross 13 Aug 2026 ยท projected 6 bars out

Weekly as of 30 Oct 16:00 ET

Price
between the two $80.94 vs 50 $92.60 / 200 $78.63
Projection
No cross projected
Test
No active test
Last cross
Golden cross week of 15 Feb 2021 ยท projected 19 bars out

4-hour as of 3 Nov 13:30 ET

Price
below both $81.81 vs 50 $82.24 / 200 $87.63
Projection
No cross projected
Test
No active test
Last cross
Death cross 5 Jun 2026 ยท projected 30 bars out

Cross history

35
crosses on record since 2018
17 golden18 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
13 Aug 2026Death flatdaily6 bars outNot tested
5 Jun 2026Death4-hour30 bars outNot tested
27 Feb 2026Golden moderatedaily26 bars outNot tested
17 Feb 2026Golden4-hour14 bars out1 bar cross test
24 Dec 2025Death flatdaily12 bars outNot tested

About LMAT

ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$22.3M
4-hour coverageYes, since Oct 2025
History on recordSince 2018
SectorHealthcare
Cap bandsmall

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.